A meta-analysis designed to compare the efficacy and safety of prasugrel with ticagrelor may have turned up few differences between the two but did show composite superiority to clopidgrel. The article Biondi-Zoccai G, Lotrionte M, Agostoni P, et al. Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes. Int J Cardiol 2010. DOI:10.1016/j.ijcard.2010.08.035 is reviewed in today’sThe Heart. Geo.
Sep 20 2010
No comments here.